Attorneys for both covered entities and drug manufacturers say they expect a significant number of filings to the newly re-established [...] …
Articles by : Rich Daly, Editor in Chief
Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Sen. John Thune (R-S.D.), who is spearheading a major bipartisan 340B reform package, told hospital executives Tuesday that 340B legislation [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal regulators recently said any decision on whether to provide Medicare Advantage (MA) plans funds to reimburse hospitals for past [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Supporters recently submitted enough signatures to qualify for the ballot a California ballot initiative that aims to codify the governor’s [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
HRSA Issues Final Regulations Revamping Process to Resolve Disputes Between 340B Providers and Manufacturers
The federal government issued the final rule early Thursday to implement a long-anticipated revision to the 340B Administrative Dispute Resolution [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal appeals court panel pressed both the AIDS Healthcare Foundation and (AHF) and Apexus, the 340B prime vendor, to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Humana asked a federal judge to dismiss Baptist Health of Alabama’s lawsuit against the company’s Medicare Advantage (MA) plans for [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After missing its self-imposed deadline of the end of 2023, the White House this week completed its review to implement [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer AbbVie recently replied to Louisiana’s request for summary judgement and defended its own such request in its ongoing [...] …